Amgen Inc. said a new study showed its drug Aimovig is an effective preventive treatment for migraine patients who have tried other treatments that either didn’t work or had intolerable side effects, the company announced Tuesday....

Subscribe to get the full story.


Are you a subscriber? Sign In